Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-011-1594-z
Full Text
Open PDFAbstract
Available in full text
Date
March 2, 2011
Authors
Publisher
Springer Science and Business Media LLC